TY - JOUR
T1 - An all-purpose antimalarial drug target
AU - Guiguemde, W. Armand
AU - Guy, R. Kiplin
PY - 2012/6/14
Y1 - 2012/6/14
N2 - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.
AB - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.
UR - http://www.scopus.com/inward/record.url?scp=84862286411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862286411&partnerID=8YFLogxK
U2 - 10.1016/j.chom.2012.05.008
DO - 10.1016/j.chom.2012.05.008
M3 - Short survey
C2 - 22704614
AN - SCOPUS:84862286411
SN - 1931-3128
VL - 11
SP - 555
EP - 557
JO - Cell Host and Microbe
JF - Cell Host and Microbe
IS - 6
ER -
